The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)

NCT04053985 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

206

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

COMBINATION_PRODUCT: TAI combine lenvatinib
DRUG: Lenvatinib

Sponsor

Sun Yat-sen University